Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive-Reference-Cited by-同舟云学术

Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive

Published:2023-07-04 Issue:1 Volume:19 Page:
ISSN:1710-1492
Container-title:Allergy, Asthma & Clinical Immunology
language:en
Short-container-title:Allergy Asthma Clin Immunol

Author:

Ju Xiaotian,Son Kiho,Jamil Rameen,Culgin Sarah,Salter Brittany,Miyasaki Kate,Fard Nahal Emami,Xiao Maria,Patel Zil,Zhang Kayla,Cowbrough Braeden,Kjarsgaard Melanie,Radford Katherine,Dvorkin-Gheva Anna,Richards Carl D.,Cox Gerard,Chagla Zain,Smieja Marek,Tunks Marcel,Alhazzani Waleed,Bowdish Dawn M.E.,Perri Dan,Nair Parameswaran K.,Sehmi Roma,Mukherjee Manali

Funder

Hamilton Academic Health Sciences Organization

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1186/s13223-023-00810-6.pdf

Reference5 articles.

1. Le Borgne P, Abensur Vuillaume L, Alamé K, Lefebvre F, Chabrier S, Bérard L, Haessler P, Gennai S, Bilbault P, Lavoignet CE. Do blood eosinophils predict in-hospital mortality or severity of Disease in SARS-CoV-2 infection? A retrospective Multicenter Study. Microorganisms. 2021;9:334.

2. Ferastraoaru D, Hudes G, Jerschow E, Jariwala S, Karagic M, de Vos G, Rosenstreich D, Ramesh M. Eosinophilia in Asthma Patients is protective against severe COVID-19 illness. J Allergy Clin Immunol Pract. 2021;9:1152–62.

3. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in hospitalized patients with Covid-19. RECOVERY collaborative group. N Engl J Med. 2021;384:693–704.

4. Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, Greenplate AR, Hwee MA, Porterfield F, Owoyemi O, Naik K, Zheng C, Galantino M, Weisman AR, Ittner CAG, Kugler EM, Baxter AE, Oniyide O, Agyekum RS, Dunn TG, Jones TK, Giannini HM, Weirick ME, McAllister CM, Babady NE, Kumar A, Widman AJ, DeWolf S, Boutemine SR, Roberts C, Budzik KR, Tollett S, Wright C, Perloff T, Sun L, Mathew D, Giles JR, Oldridge DA, Wu JE, Alanio C, Adamski S, Garfall AL, Vella LA, Kerr SJ, Cohen JV, Oyer RA, Massa R, Maillard IP, Maxwell KN, Reilly JP, Maslak PG, Vonderheide RH, Wolchok JD, Hensley SE, Wherry EJ, Meyer NJ, DeMichele AM, Vardhana SA, Mamtani R, Huang AC. CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med. 2021;27:1280–9.

5. Rha MS, Shin EC. Activation or exhaustion of CD8 + T cells in patients with COVID-19. Cell Mol Immunol. 2021;18:2325–33.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Cytokines on Coagulation Profile in COVID-19 Patients: Controlled for Socio-Demographic, Clinical, and Laboratory Parameters;Biomedicines;2024-06-10

2. The alarmin IL-33 exacerbates pulmonary inflammation and immune dysfunction in SARS-CoV-2 infection;iScience;2024-06